Gobindo Pharma Private Limited - Company Profile

It is a business services private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2023.
2023 Visakhapatnam, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Gobindo Pharma Private Limited

Gobindo Pharma Private Limited, a struck off private limited company, was established on 13 October 2023 in Visakhapatnam, Andhra Pradesh, India. it holds CIN: U46497AP2023PTC112630. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Majji Sri Sai Mohith (Director), Devyani Nalla (Director), Dinesh Naag Nalla (Director). It is based at 31-60-25/9,Kurmannapalem, Revenue Ward 58, Visakhapatnam, Andhra Pradesh, 530046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497AP2023PTC112630

  • Registration Number

    112630

  • Incorporation Date

    13 October 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 8 Months
Company report

Gobindo Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Gobindo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gobindo Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Majji Sri Sai Mohith Director 13 Oct 2023 Current
Devyani Nalla Director 13 Oct 2023 Current
Dinesh Naag Nalla Director 13 Oct 2023 Current
Majji Siri Sahasra Director 13 Oct 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gobindo Pharma.

Enhance accessibility to Gobindo Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gobindo Pharma revenue growth over time
Gobindo Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gobindo Pharma?

Unlock access to Gobindo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gobindo Pharma?

Unlock and access historical data on people associated with Gobindo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gobindo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gobindo Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gobindo Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Majji Sri Sai Mohith was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 2 years 8 months . was completed.

  • Director Appointment

    Devyani Nalla was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Dinesh Naag Nalla was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 2 years 8 months . was completed.

  • Director Appointment

    The activity Majji Siri Sahasra was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 2 years 8 months . was completed.

  • Company Incorporation

    The activity Gobindo Pharma Private Limited was registered on 13 Oct 2023 with Roc Vijayawada & aged 2 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gobindo Pharma Private Limited?

The CIN of Gobindo Pharma Private Limited is U46497AP2023PTC112630.

Where is Gobindo Pharma Private Limited headquartered?

Gobindo Pharma Private Limited is headquartered at 31-60-25/9,Kurmannapalem, Revenue Ward 58, Visakhapatnam, Andhra Pradesh, 530046.

When was Gobindo Pharma Private Limited incorporated?

Gobindo Pharma Private Limited was incorporated on 13 October 2023.

Who are the current directors of Gobindo Pharma Private Limited?

The current directors of Gobindo Pharma Private Limited are

Is Gobindo Pharma Private Limited a listed company?

Gobindo Pharma Private Limited is unlisted.

What is the capital structure of Gobindo Pharma Private Limited?

The authorized capital of Gobindo Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available